Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases

Several human inhibitor of apoptosis (IAP) family proteins function by directly inhibiting specific caspases in a mechanism that does not require IAP cleavage. In this study, however, we demonstrate that endogenous XIAP is cleaved into two fragments during apoptosis induced by the tumor necrosis factor family member Fas (CD95). The two fragments produced comprise the baculoviral inhibitory repeat (BIR) 1 and 2 domains (BIR1‐2) and the BIR3 and RING (BIR3‐Ring) domains of XIAP. Overexpression of the BIR1‐2 fragment inhibits Fas‐induced apoptosis, albeit at significantly reduced efficiency compared with full‐length XIAP. In contrast, overexpression of the BIR3‐Ring fragment results in a slight enhancement of Fas‐directed apoptosis. Thus, cleavage of XIAP may be one mechanism by which cell death programs circumvent the anti‐apoptotic barrier posed by XIAP. Interestingly, ectopic expression of the BIR3‐Ring fragment resulted in nearly complete protection from Bax‐induced apoptosis. Use of purified recombinant proteins revealed that BIR3‐Ring is a specific inhibitor of caspase‐9 whereas BIR1‐2 is specific for caspases 3 and 7. Therefore XIAP possesses two different caspase inhibitory activities which can be attributed to distinct domains within XIAP. These data may provide an explanation for why IAPs have evolved with multiple BIR domains.

[1]  John Calvin Reed,et al.  The c‐IAP‐1 and c‐IAP‐2 proteins are direct inhibitors of specific caspases , 1997, The EMBO journal.

[2]  Gerald M. Rubin,et al.  Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death , 1995, Cell.

[3]  K. Borden RING fingers and B-boxes: zinc-binding protein-protein interaction domains. , 1998 .

[4]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[5]  A. Barrett,et al.  Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. , 1986, The Biochemical journal.

[6]  J. Priess,et al.  Genetics of Programmed Cell Death , 1997 .

[7]  M. Peter,et al.  Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. , 1998, Current opinion in immunology.

[8]  S. Nagata,et al.  Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis , 1996, Nature.

[9]  R. Gascoyne,et al.  Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. , 1997, Cancer research.

[10]  A. MacKenzie,et al.  The inhibitors of apoptosis (IAPs) and their emerging role in cancer , 1998, Oncogene.

[11]  R. J. Clem,et al.  Control of programmed cell death by the baculovirus genes p35 and iap , 1994, Molecular and cellular biology.

[12]  A. Harvey,et al.  Anti- and pro-apoptotic activities of baculovirus and Drosophila IAPs in an insect cell line , 1997, Cell Death and Differentiation.

[13]  G. Salvesen,et al.  Biochemical Characteristics of Caspases-3, -6, -7, and -8* , 1997, The Journal of Biological Chemistry.

[14]  Javier Naval,et al.  Caspases are the main executioners of Fas-mediated apoptosis, irrespective of the ceramide signalling pathway , 1998, Cell Death and Differentiation.

[15]  H. Horvitz,et al.  Genetics of programmed cell death in C. elegans: past, present and future. , 1998, Trends in genetics : TIG.

[16]  D. Green,et al.  The cytotoxic cell protease granzyme B initiates apoptosis in a cell‐free system by proteolytic processing and activation of the ICE/CED‐3 family protease, CPP32, via a novel two‐step mechanism. , 1996, The EMBO journal.

[17]  B. Lenarčič,et al.  Thyroglobulin Type-1 Domains in Equistatin Inhibit Both Papain-like Cysteine Proteinases and Cathepsin D* , 1999, The Journal of Biological Chemistry.

[18]  P. Vandenabeele,et al.  Cell death induction by receptors of the TNF family: towards a molecular understanding , 1997, FEBS letters.

[19]  José Luis de la Pompa,et al.  Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo , 1998, Cell.

[20]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[21]  J C Reed,et al.  IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.

[22]  John Calvin Reed,et al.  Cytochrome c: Can't Live with It—Can't Live without It , 1997, Cell.

[23]  Y Li,et al.  [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[24]  David Wallach,et al.  Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.

[25]  J C Reed,et al.  Caspase-9 Can Be Activated without Proteolytic Processing* , 1999, The Journal of Biological Chemistry.

[26]  G. Salvesen,et al.  Granzyme B Is Inhibited by the Cowpox Virus Serpin Cytokine Response Modifier A(*) , 1995, The Journal of Biological Chemistry.

[27]  J C Reed,et al.  IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases , 1998, The EMBO journal.

[28]  S. Seshagiri,et al.  Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced , 1997, Current Biology.

[29]  L. Ellerby,et al.  Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Freemont,et al.  Does this have a familiar RING? , 1996, Trends in biochemical sciences.

[31]  Xiaodong Wang,et al.  Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.

[32]  G. Salvesen,et al.  Properties of the caspases. , 1998, Biochimica et biophysica acta.

[33]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[34]  Guy S. Salvesen,et al.  X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.

[35]  K. Borden RING fingers and B-boxes: zinc-binding protein-protein interaction domains. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[36]  J C Reed,et al.  A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases* , 1998, The Journal of Biological Chemistry.

[37]  Keisuke Kuida,et al.  Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9 , 1998, Cell.

[38]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[39]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[40]  D. Vaux,et al.  Conservation of baculovirus inhibitor of apoptosis repeat proteins (BIRPs) in viruses, nematodes, vertebrates and yeasts. , 1998, Trends in biochemical sciences.

[41]  W. Kaiser,et al.  A Mutational Analysis of the Baculovirus Inhibitor of Apoptosis Op-IAP* , 1998, The Journal of Biological Chemistry.

[42]  J C Reed,et al.  Pro-caspase-3 Is a Major Physiologic Target of Caspase-8* , 1998, The Journal of Biological Chemistry.

[43]  G. Salvesen,et al.  Caspases: Intracellular Signaling by Proteolysis , 1997, Cell.

[44]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[45]  C. Duckett,et al.  The iap genes: unique arbitrators of cell death. , 1997, Trends in cell biology.